BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3214821)

  • 21. Use of topical minoxidil therapy for androgenetic alopecia in women.
    Jacobs JP; Szpunar CA; Warner ML
    Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgenetic alopecia treated with topical minoxidil.
    De Villez RL
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):669-72. PubMed ID: 3549800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical tretinoin for hair growth promotion.
    Bazzano GS; Terezakis N; Galen W
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):880-3, 890-3. PubMed ID: 3771854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of 3% minoxidil vs. combined 3% minoxidil and Korean red ginseng in treating female pattern alopecia.
    Ryu HJ; Yoo MG; Son SW
    Int J Dermatol; 2014 Jun; 53(6):e340-2. PubMed ID: 24451023
    [No Abstract]   [Full Text] [Related]  

  • 25. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment.
    Price VH; Menefee E; Strauss PC
    J Am Acad Dermatol; 1999 Nov; 41(5 Pt 1):717-21. PubMed ID: 10534633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical minoxidil: review of efficacy.
    Katz HI
    Clin Dermatol; 1988; 6(4):195-9. PubMed ID: 3063371
    [No Abstract]   [Full Text] [Related]  

  • 27. The penetration enhancer SEPA augments stimulation of scalp hair growth by topical minoxidil in the balding stumptail macaque.
    Diani AR; Shull KL; Zaya MJ; Brunden MN
    Skin Pharmacol; 1995; 8(5):221-8. PubMed ID: 8527153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alopecia in congenital hidrotic ectodermal dysplasia responding to treatment with a combination of topical minoxidil and tretinoin.
    Melkote S; Dhurat RS; Palav A; Jerajani HR
    Int J Dermatol; 2009 Feb; 48(2):184-5. PubMed ID: 19200200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia.
    Stamatas GN; Wu J; Pappas A; Mirmirani P; McCormick TS; Cooper KD; Consolo M; Schastnaya J; Ozerov IV; Aliper A; Zhavoronkov A
    Cell Cycle; 2017; 16(17):1578-1584. PubMed ID: 28594262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
    J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
    Suchonwanit P; Iamsumang W; Rojhirunsakool S
    Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
    Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
    Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of female androgenetic alopecia with minoxidil 2%.
    Whiting DA; Jacobson C
    Int J Dermatol; 1992 Nov; 31(11):800-4. PubMed ID: 1428436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minoxidil stimulates mouse vibrissae follicles in organ culture.
    Kiesewetter F; Langer P; Schell H
    J Invest Dermatol; 1991 Feb; 96(2):295-6. PubMed ID: 2025328
    [No Abstract]   [Full Text] [Related]  

  • 35. Hair follicle biology and topical minoxidil: possible mechanisms of action.
    Headington JT
    Dermatologica; 1987; 175 Suppl 2():19-22. PubMed ID: 3319729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous effects of tocopheryl polyethylene glycol succinate (TPGS) on local hair growth promotion and systemic absorption of topically applied minoxidil in a mouse model.
    Chen CH; Sheu MT; Wu AB; Lin KP; Ho HO
    Int J Pharm; 2005 Dec; 306(1-2):91-8. PubMed ID: 16253450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An immunologic mechanism for the therapeutic efficacy of minoxidil in alopecia areata.
    Namazi MR; Handjani F
    J Drugs Dermatol; 2004; 3(2):129-30. PubMed ID: 15098965
    [No Abstract]   [Full Text] [Related]  

  • 38. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia.
    Roberts J; Desai N; McCoy J; Goren A
    Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doppler laser imaging predicts response to topical minoxidil in the treatment of female pattern hair loss.
    McCoy J; Kovacevic M; Situm M; Stanimirovic A; Bolanca Z; Goren A
    J Biol Regul Homeost Agents; 2016; 30(1):131-4. PubMed ID: 27049083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical minoxidil therapy for androgenic alopecia in the Middle East. The Middle-Eastern Topical Minoxidil Study Group.
    Karam P
    Int J Dermatol; 1993 Oct; 32(10):763-6. PubMed ID: 8225726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.